Trial Profile
A Phase I Study of BKM120 and Everolimus in Advanced Solid Malignancies
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Buparlisib (Primary) ; Everolimus (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 31 Jan 2020 Results published in the Clinical Cancer Research
- 15 Mar 2018 Status changed from active, no longer recruiting to completed.
- 01 Mar 2017 Planned End Date changed from 1 Apr 2018 to 1 May 2018.